Title: Activities of fluconazole, caspofungin, anidulafungin, and amphotericin B on planktonic and biofilm Candida species determined by microcalorimetry.
Journal: Antimicrobial agents and chemotherapy 20140501
Title: In vitro effectiveness of anidulafungin against Candida sp. biofilms.
Journal: The Journal of antibiotics 20131201
Title: Comparative in vitro fungicidal activity of echinocandins against Candida albicans in peritoneal dialysis fluids.
Journal: Mycoses 20131101
Title: Epidemiology and echinocandin susceptibility of Candida parapsilosis sensu lato species isolated from bloodstream infections at a Spanish university hospital.
Journal: The Journal of antimicrobial chemotherapy 20121101
Title: Identification and characterization of the echinocandin B biosynthetic gene cluster from Emericella rugulosa NRRL 11440.
Journal: Journal of the American Chemical Society 20121010
Title: Molecular characterization and antifungal susceptibility of the Candida parapsilosis species complex of clinical isolates from Monterrey, Mexico.
Journal: Medical mycology 20121001
Title: Anidulafungin--challenges in development and validation of an LC-MS/MS bioanalytical method validated for regulated clinical studies.
Journal: Analytical and bioanalytical chemistry 20121001
Title: Successful medical management of recalcitrant Fusarium solani keratitis: molecular identification and susceptibility patterns.
Journal: Mycopathologia 20120901
Title: In vitro and in vivo effects of echinocandins against Candida parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis.
Journal: The Journal of antimicrobial chemotherapy 20120901
Title: Anidulafungin--a new therapeutic option for Candida infections in liver transplantation.
Journal: Transplantation proceedings 20120901
Title: Flash pulmonary oedema during anidulafungin administration.
Journal: Journal of clinical pharmacy and therapeutics 20120801
Title: In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs.
Journal: The Journal of antimicrobial chemotherapy 20120801
Title: (1,3)-β-D-glucan as a prognostic marker of treatment response in invasive candidiasis.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120801
Title: Isothermal microcalorimetry for antifungal susceptibility testing of Mucorales, Fusarium spp., and Scedosporium spp.
Journal: Diagnostic microbiology and infectious disease 20120801
Title: Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff values.
Journal: Diagnostic microbiology and infectious disease 20120801
Title: Elaboration of antibiofilm surfaces functionalized with antifungal-cyclodextrin inclusion complexes.
Journal: FEMS immunology and medical microbiology 20120701
Title: Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20120701
Title: Isothermal microcalorimetry: a novel method for real-time determination of antifungal susceptibility of Aspergillus species.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20120701
Title: In vitro synergy testing of anidulafungin with fluconazole, tioconazole, 5-flucytosine and amphotericin B against some Candida spp.
Journal: Medicinal chemistry (Shariqah (United Arab Emirates)) 20120701
Title: Some chronic rhinosinusitis patients have elevated populations of fungi in their sinuses.
Journal: The Laryngoscope 20120701
Title: EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST).
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20120701
Title: Comparison of the Etest and a rapid flow cytometry-based method with the reference CLSI broth microdilution protocol M27-A3 for the echinocandin susceptibility testing of Candida spp.
Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20120601
Title: Quantitative analysis of the antifungal drug anidulafungin by LC-online SPE-MS/MS in human plasma.
Journal: Biomedical chromatography : BMC 20120601
Title: Safety of anidulafungin in solid organ transplant recipients.
Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20120601
Title: Non-clinical safety assessment and toxicokinetics of voriconazole and anidulafungin in the juvenile rat: a combination study design in support of a Paediatric Investigation Plan.
Journal: Regulatory toxicology and pharmacology : RTP 20120601
Title: In vitro efficacy of the combination of voriconazole and anidulafungin against voriconazole-resistant cyp51A mutants of Aspergillus fumigatus.
Journal: Diagnostic microbiology and infectious disease 20120601
Title: Convergent Evolution of Calcineurin Pathway Roles in Thermotolerance and Virulence in Candida glabrata.
Journal: G3 (Bethesda, Md.) 20120601
Title: Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study.
Journal: Mycoses 20120501
Title: Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.
Journal: The Journal of antimicrobial chemotherapy 20120501
Title: Evaluation of disk diffusion method compared to broth microdilution for antifungal susceptibility testing of 3 echinocandins against Aspergillus spp.
Journal: Diagnostic microbiology and infectious disease 20120501
Title: The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.
Journal: Memorias do Instituto Oswaldo Cruz 20120501
Title: [New apects in the diagnosis and therapy of dermatomycoses].
Journal: Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20120501
Title: The role of micafungin and anidulafungin in the treatment of systemic fungal infections: applications and patents for two novel echinocandins.
Journal: Recent patents on anti-infective drug discovery 20120401
Title: Combined therapy of voriconazole and anidulafungin in murine infections by Aspergillus flavus.
Journal: Mycopathologia 20120401
Title: Comparison between a high-resolution single-stage Orbitrap and a triple quadrupole mass spectrometer for quantitative analyses of drugs.
Journal: Rapid communications in mass spectrometry : RCM 20120315
Title: Influence of serum on in vitro susceptibility testing of echinocandins for Candida parapsilosis and Candida guilliermondii.
Journal: Mycoses 20120301
Title: Effect of protein binding on the activity of voriconazole alone or combined with anidulafungin against Aspergillus spp. using a time-kill methodology.
Journal: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20120301
Title: Systematic review of safety in paediatric drug trials published in 2007.
Journal: European journal of clinical pharmacology 20120201
Title: Multiple subcutaneous cysts due to Exophiala spinifera in an immunocompetent patient.
Journal: Medical mycology 20120201
Title: Comparison of anidulafungin's and fluconazole's in vivo activity in neutropenic and non-neutropenic models of invasive candidiasis.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20120201
Title: Epidemiology, risk factors and therapy of candidemia in pediatric hematological patients.
Journal: Pediatric reports 20120102
Title: Poor compliance with antifungal drug use guidelines by transplant physicians: a framework for educational guidelines and an international consensus on patient safety.
Journal: Clinical transplantation 20120101
Title: Anidulafungin: when and how? The clinician's view.
Journal: Mycoses 20120101
Title: Protein Glycosylation in Aspergillus fumigatus Is Essential for Cell Wall Synthesis and Serves as a Promising Model of Multicellular Eukaryotic Development.
Journal: International journal of microbiology 20120101
Title: Development of a 96-well catheter-based microdilution method to test antifungal susceptibility of Candida biofilms.
Journal: The Journal of antimicrobial chemotherapy 20120101
Title: [Cost analysis of 3 candins in the treatment of invasive candidiasis in adult non-neutropaenic patients in Spain].
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20120101
Title: Candida biofilms and the host: models and new concepts for eradication.
Journal: International journal of microbiology 20120101
Title: Antifungal resistance and new strategies to control fungal infections.
Journal: International journal of microbiology 20120101
Title: Echinocandin use in the neonatal intensive care unit.
Journal: The Annals of pharmacotherapy 20120101
Title: Candida spp. with acquired echinocandin resistance, France, 2004-2010.
Journal: Emerging infectious diseases 20120101
Title: Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients.
Journal: Infection and drug resistance 20120101
Title: Outcome of Antifungal Combination Therapy for Invasive Mold Infections in Hematological Patients is Independent of the Chosen Combination.
Journal: Mediterranean journal of hematology and infectious diseases 20120101
Title: Chemosensitization as a means to augment commercial antifungal agents.
Journal: Frontiers in microbiology 20120101
Title: Therapeutic use of a cationic antimicrobial peptide from the spider Acanthoscurria gomesiana in the control of experimental candidiasis.
Journal: BMC microbiology 20120101
Title: Rapid susceptibility testing and microcolony analysis of Candida spp. cultured and imaged on porous aluminum oxide.
Journal: PloS one 20120101
Title: [Persistent candidemia in a renal-pancreatic transplant patient].
Journal: Revista iberoamericana de micologia 20120101
Title: [Candida peritonitis in a haemodynamically stable patient. First choice of antifungal treatment … fluconazole?].
Journal: Revista iberoamericana de micologia 20120101
Title: [Echinocandins in a critically ill patient during continuous venovenous renal replacement].
Journal: Revista iberoamericana de micologia 20120101
Title: [Invasive candidiasis in a lung retransplantation recipient].
Journal: Revista iberoamericana de micologia 20120101
Title: Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital.
Journal: PloS one 20120101
Title: Comparison of human and soil Candida tropicalis isolates with reduced susceptibility to fluconazole.
Journal: PloS one 20120101
Title: Microcolony imaging of Aspergillus fumigatus treated with echinocandins reveals both fungistatic and fungicidal activities.
Journal: PloS one 20120101
Title: Effects of anidulafungin and voriconazole, singly and in combination, on cytokine/chemokine production by human monocyte-derived macrophages infected with Candida glabrata or activated by lipopolysaccharide.
Journal: Chemotherapy 20120101
Title: Pharmacological assessment of the medicinal potential of Acacia mearnsii De Wild.: antimicrobial and toxicity activities.
Journal: International journal of molecular sciences 20120101
Title: Inhibition of ion channels and heart beat in Drosophila by selective COX-2 inhibitor SC-791.
Journal: PloS one 20120101
Title: β-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot study.
Journal: PloS one 20120101
Title: Advances in systemic antifungal therapy.
Journal: Clinics in dermatology 20120101
Title: In vitro activity of isavuconazole against 208 Aspergillus flavus isolates in comparison with 7 other antifungal agents: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.
Journal: Diagnostic microbiology and infectious disease 20111201
Title: Current role of echinocandins in the management of invasive aspergillosis.
Journal: Current infectious disease reports 20111201
Title: Efg1 Controls caspofungin-induced cell aggregation of Candida albicans through the adhesin Als1.
Journal: Eukaryotic cell 20111201
Title: Invasive candidiasis following liver transplantation and surgical complications.
Journal: Mycoses 20111201
Title: Anidulafungin treatment in a kidney transplant recipient with hepatic damage.
Journal: Mycoses 20111201
Title: Recurrent candidaemia and pacemaker wire infection with Candida albicans.
Journal: Mycoses 20111201
Title: Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Journal: PLoS computational biology 20111201
Title: [Echinocandins].
Journal: Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia 20111201
Title: [Antifungal therapy update: new drugs and medical uses].
Journal: Enfermedades infecciosas y microbiologia clinica 20111201
Title: Characterization of Candida parapsilosis complex strains isolated from invasive fungal infections.
Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20111101
Title: Microdilution in vitro antifungal susceptibility of Exophiala dermatitidis, a systemic opportunist.
Journal: Medical mycology 20111101
Title: Efficacy of anidulafungin against biofilms of different Candida species in long-term trials of continuous flow cultivation.
Journal: Mycoses 20111101
Title: In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods.
Journal: Antimicrobial agents and chemotherapy 20111101
Title: EUCAST technical note on anidulafungin.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20111101
Title: Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antifungal, antitubercular and miscellaneous anti-infective agents.
Journal: Clinical pharmacokinetics 20111101
Title: New β-glucan inhibitors as antifungal drugs.
Journal: Expert opinion on therapeutic patents 20111001
Title: Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital.
Journal: The Journal of antimicrobial chemotherapy 20111001
Title: Efficacy of anidulafungin against Aspergillus niger in vitro and in vivo.
Journal: International journal of antimicrobial agents 20111001
Title: Post-antifungal effects and time-kill studies of anidulafungin, caspofungin, and micafungin against Candida glabrata and Candida parapsilosis.
Journal: Diagnostic microbiology and infectious disease 20111001
Title: Austrian clinical practice with anidulafungin in 2008: a multicenter survey.
Journal: Journal of chemotherapy (Florence, Italy) 20111001
Title: Breakthrough fungemia due to Candida glabrata during posaconazole prophylaxis in hematology patients treated with anidulafungin - report of 5 cases.
Journal: Journal of chemotherapy (Florence, Italy) 20111001
Title: [In vitro andulafungin susceptibility of 100 of Candida strains obtained previously to the introduction of this echinocandin in Chile].
Journal: Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia 20111001
Title: Fluconazole-, amphotericin-B-, caspofungin-, and anidulafungin-resistant Candida ciferrii: an unknown cause of systemic mycosis in a child.
Journal: Mycopathologia 20110901
Title: In vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugs.
Journal: Mycoses 20110901
Title: Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin.
Journal: Journal of medical microbiology 20110901
Title: Posaconazole: a new antifungal weapon.
Journal: Reviews on recent clinical trials 20110901
Title: Resource utilization and cost of treatment with anidulafungin or fluconazole for candidaemia and other forms of invasive candidiasis: focus on critically ill patients.
Journal: PharmacoEconomics 20110801
Title: Juvenile toxicity assessment of anidulafungin in rats: an example of navigating case-by-case study design through scientific and regulatory challenges.
Journal: Birth defects research. Part B, Developmental and reproductive toxicology 20110801
Title: Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis.
Journal: The Journal of antimicrobial chemotherapy 20110801
Title: Determination of micafungin and anidulafungin in human plasma: UV- or mass spectrometric quantification?
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110715
Title: Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).
Journal: International journal of antimicrobial agents 20110701
Title: Echinocandins: addressing outstanding questions surrounding treatment of invasive fungal infections.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110701
Title: Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 20110601
Title: Comparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus.
Journal: The Journal of antimicrobial chemotherapy 20110601
Title: Are anidulafungin or voriconazole released from polymethylmethacrylate in vitro?
Journal: Clinical orthopaedics and related research 20110501
Title: Isolation of Cryptococcus magnus and Cryptococcus chernovii from nasal cavities of pediatric patients with acute lymphoblastic leukemia.
Journal: Medical mycology 20110501
Title: Safety and pharmacokinetics of multiple-dose anidulafungin in infants and neonates.
Journal: Clinical pharmacology and therapeutics 20110501
Title: Development of an HPLC method for the determination of anidulafungin in human plasma and saline.
Journal: Journal of chromatographic science 20110501
Title: [Echinocandins in children].
Journal: Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20110501
Title: The value of amphotericin B in the treatment of invasive fungal infections.
Journal: Journal of critical care 20110401
Title: In vitro interactions among echinocandins against Aspergillus fumigatus: lack of concordance among methods.
Journal: Medical mycology 20110401
Title: Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis.
Journal: Antimicrobial agents and chemotherapy 20110401
Title: Multiple-dose pharmacokinetics of anidulafungin during continuous venovenous haemofiltration.
Journal: The Journal of antimicrobial chemotherapy 20110401
Title: Current perspectives on echinocandin class drugs.
Journal: Future microbiology 20110401
Title: Antifungal susceptibility testing of a 10-year collection of Candida spp. isolated from patients with candidemia.
Journal: Journal of chemotherapy (Florence, Italy) 20110401
Title: Comparative in vitro susceptibility of clinical isolates of Candida paparsilosis complex and other Candida species to caspofungin and anidulafungin by Etest.
Journal: Journal of chemotherapy (Florence, Italy) 20110401
Title: Characterization of Candida parapsilosis complex isolates.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20110301
Title: Additive antifungal activity of anidulafungin and human neutrophils against Candida parapsilosis biofilms.
Journal: The Journal of antimicrobial chemotherapy 20110301
Title: Anidulafungin for the treatment of invasive candidiasis.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20110301
Title: Anidulafungin: is it a promising option in the treatment of pediatric invasive fungal infections?
Journal: Expert review of anti-infective therapy 20110301
Title: In vitro activity of echinocandins against non-Candida albicans: is echinocandin antifungal activity the same?
Journal: Enfermedades infecciosas y microbiologia clinica 20110301
Title: [Drug interactions in critically-ill patients. An important factor in the use of micafungin?].
Journal: Enfermedades infecciosas y microbiologia clinica 20110301
Title: Current evidence of antifungal prophylaxis and therapy in pediatric patients.
Journal: Pediatric reports 20110224
Title: [Prevalence of Candida parapsilosis, C. orthopsilosis and C. metapsilosis in candidemia over a 5-year period at Nantes hospital and in vitro susceptibility to three echinocandins by E-test®].
Journal: Pathologie-biologie 20110201
Title: Echinocandin antifungal drugs in fungal infections: a comparison.
Journal: Drugs 20110101
Title: Fusarium infection in lung transplant patients: report of 6 cases and review of the literature.
Journal: Medicine 20110101
Title: Comparative genomics allowed the identification of drug targets against human fungal pathogens.
Journal: BMC genomics 20110101
Title: Penicillium marneffei Infection in AIDS.
Journal: Pathology research international 20110101
Title: Economic considerations of antifungal prophylaxis in patients undergoing surgical procedures.
Journal: Therapeutics and clinical risk management 20110101
Title: A Comprehensive review of abdominal infections.
Journal: World journal of emergency surgery : WJES 20110101
Title: Treatment of candidemia in adult patients without neutropenia--an inconvenient truth.
Journal: Critical care (London, England) 20110101
Title: Antifungal testing and high-throughput screening of compound library against Geomyces destructans, the etiologic agent of geomycosis (WNS) in bats.
Journal: PloS one 20110101
Title: [Antifungal prophylaxis in HIV-seropositive liver transplant recipients].
Journal: Revista iberoamericana de micologia 20110101
Title: Antimicrobial treatment of 'complicated' intra-abdominal infections and the new IDSA guidelines ? a commentary and an alternative European approach according to clinical definitions.
Journal: European journal of medical research 20110101
Title: Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin: review of the literature.
Journal: European journal of medical research 20110101
Title: Epidemiology and antifungal resistance in invasive Aspergillosis according to primary disease: review of the literature.
Journal: European journal of medical research 20110101
Title: Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis: review of the literature.
Journal: European journal of medical research 20110101
Title: Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin:review of the literature.
Journal: European journal of medical research 20110101
Title: Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin and its impact on use and costs: review of the literature.
Journal: European journal of medical research 20110101
Title: Epidemiology and antifungal resistance in invasive candidiasis.
Journal: European journal of medical research 20110101
Title: Pathogenesis and treatment of oral candidosis.
Journal: Journal of oral microbiology 20110101
Title: Antifungal susceptibility of invasive yeast isolates in Italy: the GISIA3 study in critically ill patients.
Journal: BMC infectious diseases 20110101
Title: Epidemiology of invasive fungal infections in the mediterranean area.
Journal: Mediterranean journal of hematology and infectious diseases 20110101
Title: Invasive Candida infections in patients with haematological malignancies and hematopoietic stem cell transplant recipients: current epidemiology and therapeutic options.
Journal: Mediterranean journal of hematology and infectious diseases 20110101
Title: Five-years surveillance of invasive aspergillosis in a university hospital.
Journal: BMC infectious diseases 20110101
Title: Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole.
Journal: Molecular systems biology 20110101
Title: [Invasive candidiasis in liver transplant recipient: early rescue antifungal treatment].
Journal: Revista iberoamericana de micologia 20110101
Title: Post-transplant aspergillosis and the role of combined neurosurgical and antifungal therapies under belatacept immunosuppression.
Journal: Surgical neurology international 20110101
Title: Epidemiology and treatment approaches in management of invasive fungal infections.
Journal: Clinical epidemiology 20110101
Title: Emerging fungal infections in immunocompromised patients.
Journal: F1000 medicine reports 20110101
Title: Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome.
Journal: BMC infectious diseases 20110101
Title: Efficacy and safety of current drug therapies for invasive aspergillosis.
Journal: Pharmacology 20110101
Title: Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: support for the 2009 IDSA treatment guidelines for candidiasis.
Journal: Critical care (London, England) 20110101
Title: Candida colonization index in patients admitted to an ICU.
Journal: International journal of molecular sciences 20110101
Title: Antimicrobial therapy for the treatment of opportunistic infections in HIV/AIDS patients: a critical appraisal.
Journal: HIV/AIDS (Auckland, N.Z.) 20110101
Title: [Susceptibility to antifungal agents of Candida sp. and biofilm formation].
Journal: Medycyna doswiadczalna i mikrobiologia 20110101
Title: Radioimmunotherapy of fungal diseases: the therapeutic potential of cytocidal radiation delivered by antibody targeting fungal cell surface antigens.
Journal: Frontiers in microbiology 20110101
Title: Spontaneous esophageal perforation in a patient with mixed connective tissue disease.
Journal: The open rheumatology journal 20110101
Title: Species distribution and susceptibility profile of yeasts isolated from blood cultures: results of a multicenter active laboratory-based surveillance study in Argentina.
Journal: Revista Argentina de microbiologia 20110101
Title: Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole-N-oxide, anidulafungin, and caspofungin.
Journal: Antimicrobial agents and chemotherapy 20101201
Title: Clinical experience of anidulafungin for the treatment of patients with documented candidemia.
Journal: Journal of chemotherapy (Florence, Italy) 20101201
Title: Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008-2009).
Journal: Diagnostic microbiology and infectious disease 20101101
Title: Chronic airway colonization by Scedosporium apiospermum with a fatal outcome in a patient with cystic fibrosis.
Journal: Medical mycology 20101101
Title: Recent advances in the treatment of mucormycosis.
Journal: Current infectious disease reports 20101101
Title: Septic bilateral pulmonary candidiasis successfully treated with anidulafungin therapy in two patients with peritoneal carcinomatosis.
Journal: The Journal of antimicrobial chemotherapy 20101001
Title: Pharmacokinetics, antifungal activity and clinical efficacy of anidulafungin in the treatment of fungal infections.
Journal: Expert opinion on drug metabolism & toxicology 20101001
Title: Role of echinocandins in the management of fungal infections in neonates.
Journal: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 20101001
Title: Screening for drug-resistant Candida yeasts with chromogenic agar.
Journal: Medical mycology 20100901
Title: Evaluation of the Etest method for susceptibility testing of Aspergillus spp. and Fusarium spp. to three echinocandins.
Journal: Medical mycology 20100901
Title: Rhinocladiella aquaspersa, proven agent of verrucous skin infection and a novel type of chromoblastomycosis.
Journal: Medical mycology 20100801
Title: [Anidulafungin: a new therapeutic option in systemic candidiasis].
Journal: Medecine et maladies infectieuses 20100801
Title: Efficacy of anidulafungin, caspofungin and fluconazole in the early phase of infection in a neutropenic murine invasive candidiasis model.
Journal: International journal of antimicrobial agents 20100701
Title: Antifungal susceptibility profile of human-pathogenic species of Lichtheimia.
Journal: Antimicrobial agents and chemotherapy 20100701
Title: Case report 4: Elderly patient with concomitant conditions.
Journal: Mycoses 20100701
Title: Case report 5: Intensive care unit patient assessed using the Candida Score.
Journal: Mycoses 20100701
Title: Case report 6: Candidaemia in a high risk liver transplant recipient.
Journal: Mycoses 20100701
Title: Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents.
Journal: The Journal of infectious diseases 20100615
Title: [Therapy of candidemia and invasive candidiasis according to guidelines].
Journal: Mycoses 20100501
Title: Traditional and emerging antifungal therapies.
Journal: Proceedings of the American Thoracic Society 20100501
Title: In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp.
Journal: Antimicrobial agents and chemotherapy 20100401
Title: Combination of caspofungin or anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro.
Journal: International journal of antimicrobial agents 20100401
Title: In vitro activity of nine antifungal agents against clinical isolates of Aspergillus calidoustus.
Journal: Medical mycology 20100201
Title: Fungal echinocandin resistance.
Journal: Fungal genetics and biology : FG & B 20100201
Title: Fungicidal activity of anidulafungin in serum from patients does not correlate to its susceptible breakpoint against Candida spp.
Journal: The Journal of antimicrobial chemotherapy 20100201
Title: Reverse genetics in Candida albicans predicts ARF cycling is essential for drug resistance and virulence.
Journal: PLoS pathogens 20100201
Title: Echinocandins: A ray of hope in antifungal drug therapy.
Journal: Indian journal of pharmacology 20100201
Title: [Antifungal combination therapy in invasive fungal infections].
Journal: La Revue de medecine interne 20100101
Title: Medical claims and current applications of the potent echinocandin antifungals.
Journal: Recent patents on anti-infective drug discovery 20100101
Title: The echinocandins: three useful choices or three too many?
Journal: International journal of antimicrobial agents 20100101
Title: A clinical review of echinocandins in pediatric patients.
Journal: The Annals of pharmacotherapy 20100101
Title: Species distribution and susceptibility profile of Candida species in a Brazilian public tertiary hospital.
Journal: BMC research notes 20100101
Title: Echinocandin treatment of pneumocystis pneumonia in rodent models depletes cysts leaving trophic burdens that cannot transmit the infection.
Journal: PloS one 20100101
Title: A focus on intra-abdominal infections.
Journal: World journal of emergency surgery : WJES 20100101
Title: Development of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence.
Journal: PloS one 20100101
Title: A formal model for analyzing drug combination effects and its application in TNF-alpha-induced NFkappaB pathway.
Journal: BMC systems biology 20100101
Title: Genotypic and phenotypic properties of Candida parapsilosis sensu strictu strains isolated from different geographic regions and body sites.
Journal: BMC microbiology 20100101
Title: Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit.
Journal: Critical care (London, England) 20100101
Title: Fungal echinocandin resistance.
Journal: F1000 biology reports 20100101
Title: A rare case of toxic epidermal necrolysis with unexpected Fever resulting from dengue virus.
Journal: Case reports in dermatology 20100101
Title: Current strategies for the prevention and management of central line-associated bloodstream infections.
Journal: Infection and drug resistance 20100101
Title: Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection.
Journal: HIV/AIDS (Auckland, N.Z.) 20100101
Title: Treatment of invasive candidiasis with echinocandins.
Journal: Mycoses 20091101
Title: Neonatal peritoneal candidiasis successfully treated with anidulafungin add-on therapy.
Journal: The Annals of pharmacotherapy 20091101
Title: Echinocandins: the newest class of antifungals.
Journal: The Annals of pharmacotherapy 20091001
Title: Delivery of antifungal agents using bioactive and nonbioactive bone cements.
Journal: The Annals of pharmacotherapy 20091001
Title: New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
Journal: Expert review of anti-infective therapy 20091001
Title: Extended daily dialysis does not affect the pharmacokinetics of anidulafungin.
Journal: International journal of antimicrobial agents 20090901
Title: Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination.
Journal: Expert opinion on investigational drugs 20090901
Title: Anidulafungin is fungicidal and exerts a variety of postantifungal effects against Candida albicans, C. glabrata, C. parapsilosis, and C. krusei isolates.
Journal: Antimicrobial agents and chemotherapy 20090801
Title: Echinocandins: pharmacokinetic and therapeutic issues.
Journal: Current medical research and opinion 20090701
Title: Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin.
Journal: PLoS pathogens 20090701
Title: Lost in translation: differences in antimicrobial indication approval policies between the United States and Europe.
Journal: Clinical therapeutics 20090701
Title: Overview of antifungal agents.
Journal: Clinics in chest medicine 20090601
Title: Rapid Hemodynamic Deterioration and Death due to Acute Severe Refractory Septic Shock.
Journal: Journal of clinical medicine research 20090601
Title: The changing face of epidemiology of invasive fungal disease in Europe.
Journal: Mycoses 20090501
Title: [In vitro antifungal activity of micafungin].
Journal: Revista iberoamericana de micologia 20090331
Title: [Micafungin: experimental therapy of fungal infections in animal models].
Journal: Revista iberoamericana de micologia 20090331
Title: Antifungal activity of anidulafungin, a product of Aspergillus nidulans, against Aspergillus nidulans.
Journal: International journal of antimicrobial agents 20090301
Title: In vitro and in vivo studies to characterize the clearance mechanism and potential cytochrome P450 interactions of anidulafungin.
Journal: Antimicrobial agents and chemotherapy 20090301
Title: Newer antifungal agents for invasive fungal infections in patients with haematological malignancy.
Journal: British journal of haematology 20090301
Title: Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20090301
Title: Utilization and dosage pattern of echinocandins for treatment of fungal infections in US hospital practice.
Journal: Current medical research and opinion 20090201
Title: Clinical indications for newer antifungal agents.
Journal: Journal of hospital medicine 20090201
Title: Anidulafungin: new drug. Invasive candidiasis: just another echinocandin.
Journal: Prescrire international 20090201
Title: Pharmacology and antifungal properties of anidulafungin, a new echinocandin.
Journal: Pharmacotherapy 20090101
Title: Antifungal treatment for invasive Candida infections: a mixed treatment comparison meta-analysis.
Journal: Annals of clinical microbiology and antimicrobials 20090101
Title: Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B.
Journal: Critical care (London, England) 20090101
Title: Successful treatment of Candida parapsilosis and Pseudomonas aeruginosa infection using medical and surgical management in an injecting drug user with mitral and aortic valve endocarditis: a case report.
Journal: Journal of medical case reports 20090101
Title: Recent advances in the management of invasive candidiasis: role of anidulafungin.
Journal: Drugs 20090101
Title: Clinical aspects of invasive candidiasis: endocarditis and other localized infections.
Journal: Drugs 20090101
Title: Invasive fungal infections: the challenge continues.
Journal: Drugs 20090101
Title: Pharmacological properties of antifungal drugs with a focus on anidulafungin.
Journal: Drugs 20090101
Title: Anidulafungin, a new echinocandin: in vitro activity.
Journal: Drugs 20090101
Title: Anidulafungin, a new echinocandin: effectiveness and tolerability.
Journal: Drugs 20090101
Title: Conclusions. Anidulafungin is a new echinocandin developed for more effective treatment of serious systemic fungal infections.
Journal: Drugs 20090101
Title: Review of the pharmacology and clinical studies of micafungin.
Journal: Drug design, development and therapy 20090101
Title: Anidulafungin and its role in candida infections.
Journal: Infection and drug resistance 20090101
Title: Proposed quality control ranges for 2-microg anidulafungin disk diffusion testing and ability of the method to detect strains with elevated echinocandin MIC values.
Journal: Diagnostic microbiology and infectious disease 20081201
Title: Anidulafungin: a novel echinocandin for candida infections.
Journal: Future microbiology 20081201
Title: Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts?
Journal: Therapeutics and clinical risk management 20081201
Title: Amphotericin B lipid complex: treatment of invasive fungal infections in patients refractory to or intolerant of amphotericin B deoxycholate.
Journal: Therapeutics and clinical risk management 20081201
Title: [Current status of invasive fungal infections. New diagnostic techniques and antifungal agents].
Journal: Enfermedades infecciosas y microbiologia clinica 20081201
Title: [In vitro activity of anidulafungin. Comparison with the activity of other echinocandins].
Journal: Enfermedades infecciosas y microbiologia clinica 20081201
Title: [Pharmacokinetics and pharmacodynamics: interactions and adverse effects. Comparison with other echinocandins].
Journal: Enfermedades infecciosas y microbiologia clinica 20081201
Title: [Current treatment of candidemia. Role of anidulafungin].
Journal: Enfermedades infecciosas y microbiologia clinica 20081201
Title: [Role of anidulafungin in solid organ transplant recipients].
Journal: Enfermedades infecciosas y microbiologia clinica 20081201
Title: [Role of anidulafungin in critically ill patients].
Journal: Enfermedades infecciosas y microbiologia clinica 20081201
Title: [Potential of anidulafungin in hematological patients].
Journal: Enfermedades infecciosas y microbiologia clinica 20081201
Title: [Potential of anidulafungin in combined therapy].
Journal: Enfermedades infecciosas y microbiologia clinica 20081201
Title: A sterol-regulatory element binding protein is required for cell polarity, hypoxia adaptation, azole drug resistance, and virulence in Aspergillus fumigatus.
Journal: PLoS pathogens 20081101
Title: Management of invasive Candida infections in non-neutropenic critically ill patients: from prophylaxis to early therapy.
Journal: International journal of antimicrobial agents 20081101
Title: Anidulafungin in the treatment of patients with invasive candidiasis.
Journal: International journal of antimicrobial agents 20081101
Title: Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasis.
Journal: Diagnostic microbiology and infectious disease 20081001
Title: Significant differences in drug susceptibility among species in the Candida parapsilosis group.
Journal: Diagnostic microbiology and infectious disease 20080901
Title: Anidulafungin: a drug evaluation of a new echinocandin.
Journal: Expert opinion on pharmacotherapy 20080901
Title: Antifungal treatment strategies in high risk patients.
Journal: Mycoses 20080901
Title: Treatment of invasive candidal infections: systematic review and meta-analysis.
Journal: Mayo Clinic proceedings 20080901
Title: [What distinctions do Candida biofilms have to offer?].
Journal: Mycoses 20080901
Title: In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates.
Journal: Antimicrobial agents and chemotherapy 20080801
Title: Update in infectious disease treatment.
Journal: Cleveland Clinic journal of medicine 20080801
Title: Posaconazole in the management of refractory invasive fungal infections.
Journal: Therapeutics and clinical risk management 20080801
Title: Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae.
Journal: The Journal of infectious diseases 20080715
Title: A phase 2, open-label study of the safety and efficacy of intravenous anidulafungin as a treatment for azole-refractory mucosal candidiasis.
Journal: Journal of acquired immune deficiency syndromes (1999) 20080701
Title: [Echinocandins in invasive candidiasis].
Journal: Medizinische Klinik (Munich, Germany : 1983) 20080615
Title: [Anidulafungin in the invasive fungal infection: current topics].
Journal: Revista iberoamericana de micologia 20080601
Title: [Anidulafungin: a new echinocandin for the treatment of mycosis].
Journal: Revista iberoamericana de micologia 20080601
Title: [The fungal cell wall and the mechanism of action of anidulafungin].
Journal: Revista iberoamericana de micologia 20080601
Title: [In vitro antifungal activity of anidulafungin].
Journal: Revista iberoamericana de micologia 20080601
Title: [Anidulafungin: a new therapeutic approach in antifungal therapy. Pharmacology of anidulafungin].
Journal: Revista iberoamericana de micologia 20080601
Title: Mechanisms of resistance to antifungal agents: yeasts and filamentous fungi.
Journal: Revista iberoamericana de micologia 20080601
Title: [Therapeutic efficacy of anidulafungin for the treatment of oesophageal candidiasis, candidemia and invasive candidiasis].
Journal: Revista iberoamericana de micologia 20080601
Title: [Anidulafungin: experimental therapy of fungal infections in animal models].
Journal: Revista iberoamericana de micologia 20080601
Title: [Activity of anidulafungin against Candida biofilms].
Journal: Revista iberoamericana de micologia 20080601
Title: [The role of anidulafungin therapy in solid organ transplant recipients].
Journal: Revista iberoamericana de micologia 20080601
Title: [Anidulafungin].
Journal: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20080601
Title: [Recommendations of antifungal treatment in patients with low grade immunosuppression].
Journal: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20080601
Title: Liposomal amphotericin B: what is its role in 2008?
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20080501
Title: Stimulation of chitin synthesis rescues Candida albicans from echinocandins.
Journal: PLoS pathogens 20080401
Title: Paradoxical growth effects of the echinocandins caspofungin and micafungin, but not of anidulafungin, on clinical isolates of Candida albicans and C. dubliniensis.
Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20080201
Title: In vivo pharmacodynamic characterization of anidulafungin in a neutropenic murine candidiasis model.
Journal: Antimicrobial agents and chemotherapy 20080201
Title: Management of Candida infections in the adult intensive care unit.
Journal: Expert opinion on pharmacotherapy 20080201
Title: Anidulafungin in the treatment of invasive fungal infections.
Journal: Therapeutics and clinical risk management 20080201
Title: Advances in antifungal therapy.
Journal: Annual review of medicine 20080101
Title: Early clinical experience with anidulafungin at a large tertiary care medical center.
Journal: Pharmacotherapy 20080101
Title: Anidulafungin was noninferior to fluconazole for invasive candidiasis.
Journal: ACP journal club 20080101
Title: Propofol lipidic infusion promotes resistance to antifungals by reducing drug input into the fungal cell.
Journal: BMC microbiology 20080101
Title: Bench-to-bedside review: Candida infections in the intensive care unit.
Journal: Critical care (London, England) 20080101
Title: Patients at high risk of invasive fungal infections: when and how to treat.
Journal: Drugs 20080101
Title: Micafungin: a review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections.
Journal: Drugs 20080101
Title: Micafungin in the treatment of invasive candidiasis and invasive aspergillosis.
Journal: Infection and drug resistance 20080101
Title: A review of clinical experience with newer antifungals in children.
Journal: The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG 20080101
Title: [In vitro activity of amphotericin B and anidulafungin against Candida spp. biofilms].
Journal: Revista iberoamericana de micologia 20071231
Title: A review of the new antifungals: posaconazole, micafungin, and anidulafungin.
Journal: Journal of drugs in dermatology : JDD 20071201
Title: Update on the treatment of disseminated fusariosis: Focus on voriconazole.
Journal: Therapeutics and clinical risk management 20071201
Title: Mould breakthrough in immunosuppressed adults receiving anidulafungin: a report of 2 cases.
Journal: The Journal of infection 20071101
Title: Antifungal drug discovery, six new molecules patented after 10 years of feast: why do we need new patented drugs apart from new strategies?
Journal: Recent patents on anti-infective drug discovery 20071101
Title: Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients.
Journal: Intensive care medicine 20071001
Title: Anidulafungin and fluconazole for candidiasis.
Journal: The New England journal of medicine 20070927
Title: Anidulafungin and fluconazole for candidiasis.
Journal: The New England journal of medicine 20070927
Title: Susceptibility patterns of Candida species recovered from Canadian intensive care units.
Journal: Journal of critical care 20070901
Title: Recent advances in antifungal agents.
Journal: Mini reviews in medicinal chemistry 20070901
Title: One year prospective survey of Candida bloodstream infections in Scotland.
Journal: Journal of medical microbiology 20070801
Title: Role of posaconazole in the management of oropharyngeal and esophageal candidiasis.
Journal: Therapeutics and clinical risk management 20070801
Title: Development of anidulafungin for disk diffusion susceptibility testing against Candida spp.
Journal: Diagnostic microbiology and infectious disease 20070701
Title: Nongastroesophageal reflux disease-related infectious, inflammatory and injurious disorders of the esophagus.
Journal: Current opinion in gastroenterology 20070701
Title: A comparative evaluation of properties and clinical efficacy of the echinocandins.
Journal: Expert opinion on pharmacotherapy 20070701
Title: Anidulafungin versus fluconazole for invasive candidiasis.
Journal: The New England journal of medicine 20070614
Title: Echinocandins--first-choice or first-line therapy for invasive candidiasis?
Journal: The New England journal of medicine 20070614
Title: Anidulafungin does not require dosage adjustment in subjects with varying degrees of hepatic or renal impairment.
Journal: Journal of clinical pharmacology 20070401
Title: The echinocandins.
Journal: Pharmacotherapy 20070301
Title: Lack of pharmacokinetic interaction between anidulafungin and tacrolimus.
Journal: Journal of clinical pharmacology 20070301
Title: Essential gene identification and drug target prioritization in Aspergillus fumigatus.
Journal: PLoS pathogens 20070301
Title: Comparison of echinocandin antifungals.
Journal: Therapeutics and clinical risk management 20070301
Title: Anidulafungin: a new echinocandin for candidal infections.
Journal: Expert review of anti-infective therapy 20070201
Title: New drugs 07, part I.
Journal: Nursing 20070201
Title: Fungal infections of the CNS: treatment strategies for the immunocompromised patient.
Journal: CNS drugs 20070101
Title: Anidulafungin--state of affairs from a clinical perspective.
Journal: Mycoses 20070101
Title: Role of micafungin in the antifungal armamentarium.
Journal: Current medicinal chemistry 20070101
Title: Antifungal agents in neonates: issues and recommendations.
Journal: Paediatric drugs 20070101
Title: Update on new antifungal therapy.
Journal: AACN advanced critical care 20070101
Title: Anidulafungin: an evidence-based review of its use in invasive fungal infections.
Journal: Core evidence 20070101
Title: The safety of anidulafungin.
Journal: Expert opinion on drug safety 20061101
Title: Echinocandins in the management of invasive fungal infections, Part 2.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20061001
Title: Echinocandins in the management of invasive fungal infections, part 1.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20060915
Title: Echinocandins for candidemia in adults without neutropenia.
Journal: The New England journal of medicine 20060914
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20060901
Title: Anidulafungin: a new echinocandin for the treatment of fungal infections.
Journal: Drugs of today (Barcelona, Spain : 1998) 20060801
Title: Anidulafungin: a novel echinocandin.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060715
Title: Voriconazole in the management of nosocomial invasive fungal infections.
Journal: Therapeutics and clinical risk management 20060601
Title: Anidulafungin (Eraxis) for Candida infections.
Journal: The Medical letter on drugs and therapeutics 20060522
Title: Emerging echinocandins for treatment of invasive fungal infections.
Journal: Expert opinion on emerging drugs 20060501
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20060501
Title: Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis.
Journal: The Journal of antimicrobial chemotherapy 20060401
Title: Echinocandin antifungals: review and update.
Journal: Expert review of anti-infective therapy 20060401
Title: In vitro interactions of anidulafungin with azole antifungals, amphotericin B and 5-fluorocytosine against Candida species.
Journal: International journal of antimicrobial agents 20060201
Title: New drugs: lubiprostone, ranolazine, and anidulafungin.
Journal: Journal of the American Pharmacists Association : JAPhA 20060101
Title: Another option for fungal infections.
Journal: FDA consumer 20060101
Title: The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applications.
Journal: Pharmacology 20060101
Title: Safety and pharmacokinetics of coadministered voriconazole and anidulafungin.
Journal: Journal of clinical pharmacology 20051201
Title: Advances in antifungal therapy.
Journal: The Pediatric infectious disease journal 20051001
Title: Management of systemic fungal infections: alternatives to itraconazole.
Journal: The Journal of antimicrobial chemotherapy 20050901
Title: Acquisitions not a cure for anti-infectives.
Journal: Nature reviews. Drug discovery 20050901
Title: Echinocandins: role in antifungal therapy, 2005.
Journal: Expert opinion on pharmacotherapy 20050801
Title: Antifungal agents in children.
Journal: Pediatric clinics of North America 20050601
Title: Anidulafungin: a new echinocandin with a novel profile.
Journal: Clinical therapeutics 20050601
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20050501
Title: Overview of transplant mycology.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050415
Title: Compatibility of anidulafungin with other drugs during simulated Y-site administration.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050415
Title: Assessment of the safety and pharmacokinetics of anidulafungin when administered with cyclosporine.
Journal: Journal of clinical pharmacology 20050201
Title: New antifungal drugs and the pediatric cancer patient: current status of clinical development.
Journal: Klinische Padiatrie 20050101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20050101
Title: Initial results from a longitudinal international surveillance programme for anidulafungin (2003).
Journal: The Journal of antimicrobial chemotherapy 20041201
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20041201
Title: Pharmacokinetics/pharmacodynamics of echinocandins.
Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20041101
Title: Management of invasive mycoses in hematology patients: current approaches.
Journal: Oncology (Williston Park, N.Y.) 20041101
Title: A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040915
Title: Echinocandins: ask not what they can do for esophageal candidiasis--ask what studies of esophageal candidiasis can do for them.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040915
Title: Effects of caspofungin (MK-0991) and anidulafungin (LY303366) on phagocytosis, oxidative burst and killing of Candida albicans by human phagocytes.
Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20040901
Title: Anidulafungin: an echinocandin antifungal.
Journal: Expert opinion on investigational drugs 20040901
Title: Anidulafungin: review of a new echinocandin antifungal agent.
Journal: Expert review of anti-infective therapy 20040801
Title: Population pharmacokinetic analysis of anidulafungin, an echinocandin antifungal.
Journal: Journal of clinical pharmacology 20040601
Title: Fungal biofilms and drug resistance.
Journal: Emerging infectious diseases 20040101
Title: Newer systemic antifungal agents : pharmacokinetics, safety and efficacy.
Journal: Drugs 20040101
Title: Anidulafungin.
Journal: Drugs 20040101
Title: In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.
Journal: Revista iberoamericana de micologia 20031201
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20031101
Title: Anidulafungin Vicuron.
Journal: IDrugs : the investigational drugs journal 20031001
Title: The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy.
Journal: Expert opinion on investigational drugs 20030801
Title: Trends in frequency and in vitro susceptibilities to antifungal agents, including voriconazole and anidulafungin, of Candida bloodstream isolates. Results from a six-year study (1996-2001).
Journal: Diagnostic microbiology and infectious disease 20030801
Title: New antifungal agents.
Journal: Dermatologic clinics 20030701
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20030601
Title: In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp.
Journal: Diagnostic microbiology and infectious disease 20030201
Title: Antifungal activity of the echinocandin anidulafungin (VER002, LY-303366) against yeast pathogens: a comparative study with M27-A microdilution method.
Journal: The Journal of antimicrobial chemotherapy 20030101
Title: Anidulafungin: ECB, LY 303366, V-echinocandin, VEC, VER 002, VER-02.
Journal: Drugs in R&D 20030101
Title: Antifungal activities of fluconazole, caspofungin (MK0991), and anidulafungin (LY 303366) alone and in combination against Candida spp. and Crytococcus neoformans via time-kill methods.
Journal: Diagnostic microbiology and infectious disease 20020501
Title: Clinical efficacy of echinocandin antifungals.
Journal: Current opinion in infectious diseases 20011201
Title: The echinocandins, first novel class of antifungals in two decades: will they live up to their promise?
Journal: International journal of clinical practice 20011101
Title: Clinical microbiology and infectious diseases. Management of fungal infections.
Journal: IDrugs : the investigational drugs journal 20010701
Title: Hitting a new target with echinocandins. Why chase something else?
Journal: Current opinion in investigational drugs (London, England : 2000) 20010401
Title: Update on antifungals targeted to the cell wall: focus on beta-1,3-glucan synthase inhibitors.
Journal: Expert opinion on investigational drugs 20010201
Title: Regional-dependent intestinal absorption and meal composition effects on systemic availability of LY303366, a lipopeptide antifungal agent, in dogs.
Journal: Journal of pharmaceutical sciences 20010101
Title: In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20010101
Title: Efficacies of two new antifungal agents, the triazole ravuconazole and the echinocandin LY-303366, in an experimental model of invasive aspergillosis.
Journal: Antimicrobial agents and chemotherapy 20001201
Title: Drug interaction studies of a glucan synthase inhibitor (LY 303366) and a chitin synthase inhibitor (Nikkomycin Z) for inhibition and killing of fungal pathogens.
Journal: Antimicrobial agents and chemotherapy 20000901
Title: Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B.
Journal: The Journal of antimicrobial chemotherapy 20000901
Title: In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients.
Journal: The Journal of antimicrobial chemotherapy 19991101
Title: Antifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbits.
Journal: Antimicrobial agents and chemotherapy 19981101
Title: Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts.
Journal: Journal of clinical microbiology 19981001
Title: In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp.
Journal: Antimicrobial agents and chemotherapy 19981001
Title: Efficacy of LY303366 against amphotericin B-susceptible and -resistant Aspergillus fumigatus in a murine model of invasive aspergillosis.
Journal: Antimicrobial agents and chemotherapy 19980401
Title: The synthesis and antifungal activity of nitrogen containing hemiaminal ethers of LY303366.
Journal: The Journal of antibiotics 19980201
Title: In vitro kill curves of a new semisynthetic echinocandin, LY-303366, against fluconazole-sensitive and -resistant Candida species.
Journal: Antimicrobial agents and chemotherapy 19971101
Title: Comparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformans.
Journal: Antimicrobial agents and chemotherapy 19970901
Title: In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species.
Journal: Antimicrobial agents and chemotherapy 19970401
Title: Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo.
Journal: Antimicrobial agents and chemotherapy 19960801
Title: Zhanel GG, et al. In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species. Antimicrob Agents Chemother. 1997 Apr;41(4):863-5
Title: Locke JB, et al. Characterization of In Vitro Resistance Development to the Novel Echinocandin CD101 in Candida Species. Antimicrob Agents Chemother. 2016 Sep 23;60(10):6100-7.
